Connection

Ayad Jaffa to Animals

Back to Details
This is a "connection" page, showing publications Ayad Jaffa has written about Animals.
Ayad Jaffa
Connection Strength
0.808
Animals
  1. Heteromerization fingerprints between bradykinin B2 and thromboxane TP receptors in native cells. PLoS One. 2019; 14(5):e0216908.
    View in: PubMed
    Score: 0.049
  2. Proteome profiling in the aorta and kidney of type 1 diabetic rats. PLoS One. 2017; 12(11):e0187752.
    View in: PubMed
    Score: 0.044
  3. Mechanisms of bradykinin-induced expression of connective tissue growth factor and nephrin in podocytes. Am J Physiol Renal Physiol. 2015 Dec 01; 309(11):F980-90.
    View in: PubMed
    Score: 0.038
  4. Novel mechanism of plasma prekallikrein (PK) activation by vascular smooth muscle cells: evidence of the presence of PK activator. J Biol Regul Homeost Agents. 2014 Oct-Dec; 28(4):587-603.
    View in: PubMed
    Score: 0.036
  5. Creatinine metabolite, HMH (5-hydroxy-1-methylhydantoin; NZ-419), modulates bradykinin-induced changes in vascular smooth muscle cells. J Recept Signal Transduct Res. 2014 Jun; 34(3):195-200.
    View in: PubMed
    Score: 0.035
  6. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers. J Biol Chem. 2013 Jun 28; 288(26):18872-84.
    View in: PubMed
    Score: 0.033
  7. Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetes. PLoS One. 2012; 7(9):e44714.
    View in: PubMed
    Score: 0.031
  8. Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells. Mol Endocrinol. 2012 May; 26(5):833-45.
    View in: PubMed
    Score: 0.030
  9. Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors. J Biol Chem. 2010 Nov 05; 285(45):35206-15.
    View in: PubMed
    Score: 0.027
  10. Evidence for prostacyclin and cAMP upregulation by bradykinin and insulin-like growth factor 1 in vascular smooth muscle cells. J Recept Signal Transduct Res. 2010 Apr; 30(2):61-71.
    View in: PubMed
    Score: 0.026
  11. Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy. Am J Physiol Renal Physiol. 2007 Oct; 293(4):F1026-35.
    View in: PubMed
    Score: 0.022
  12. Evidence for low-density lipoprotein-induced expression of connective tissue growth factor in mesangial cells. Kidney Int. 2005 Apr; 67(4):1286-96.
    View in: PubMed
    Score: 0.019
  13. Mechanisms through which bradykinin promotes glomerular injury in diabetes. Am J Physiol Renal Physiol. 2005 Mar; 288(3):F483-92.
    View in: PubMed
    Score: 0.018
  14. Mechanisms of angiotensin II-induced expression of B2 kinin receptors. Am J Physiol Heart Circ Physiol. 2004 Mar; 286(3):H926-32.
    View in: PubMed
    Score: 0.017
  15. Role of reactive oxygen species in bradykinin-induced proliferation of vascular smooth muscle cells. Biol Res. 2004; 37(3):419-30.
    View in: PubMed
    Score: 0.017
  16. Diabetes modulates the expression of glomerular kinin receptors. Int Immunopharmacol. 2002 Dec; 2(13-14):1771-9.
    View in: PubMed
    Score: 0.016
  17. Induction of B(1)-kinin receptors in vascular smooth muscle cells: cellular mechanisms of map kinase activation. Hypertension. 2001 Sep; 38(3 Pt 2):602-5.
    View in: PubMed
    Score: 0.014
  18. Regulation of B(2)-kinin receptors by glucose in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2001 Apr; 280(4):H1537-46.
    View in: PubMed
    Score: 0.014
  19. Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-beta and MAPK. Am J Physiol Heart Circ Physiol. 2000 Dec; 279(6):H2829-37.
    View in: PubMed
    Score: 0.014
  20. Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells. Diabetes. 2000 Dec; 49(12):2160-9.
    View in: PubMed
    Score: 0.014
  21. Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-fos induction in vascular cells. Hypertension. 2000 Apr; 35(4):942-7.
    View in: PubMed
    Score: 0.013
  22. Calcium-calmodulin mediates bradykinin-induced MAPK phosphorylation and c-fos induction in vascular cells. Am J Physiol. 1999 09; 277(3):H1061-8.
    View in: PubMed
    Score: 0.013
  23. Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol. 1999 08; 277(2):C253-61.
    View in: PubMed
    Score: 0.013
  24. Heme oxygenase-1-Dependent anti-inflammatory effects of atorvastatin in zymosan-injected subcutaneous air pouch in mice. PLoS One. 2019; 14(5):e0216405.
    View in: PubMed
    Score: 0.012
  25. Cellular distribution of exogenous aprotinin in the rat kidney. Biol Chem. 1998 Oct; 379(10):1271-7.
    View in: PubMed
    Score: 0.012
  26. Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms. Prog Neurobiol. 2018 Jun - Aug; 165-167:26-50.
    View in: PubMed
    Score: 0.011
  27. Induction of renal kallikrein and renin gene expression by insulin and IGF-I in the diabetic rat. Diabetes. 1997 Dec; 46(12):2049-56.
    View in: PubMed
    Score: 0.011
  28. Bradykinin induces tubulin phosphorylation and nuclear translocation of MAP kinase in mesangial cells. Am J Physiol. 1997 12; 273(6):F916-24.
    View in: PubMed
    Score: 0.011
  29. Modulation of renal kallikrein production by dietary protein in streptozotocin-induced diabetic rats. J Am Soc Nephrol. 1996 May; 7(5):721-7.
    View in: PubMed
    Score: 0.010
  30. Skeletal muscle kallikrein. Potential role in metabolic regulation. Diabetes. 1996 Jan; 45 Suppl 1:S20-3.
    View in: PubMed
    Score: 0.010
  31. Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment. PLoS One. 2015; 10(6):e0128601.
    View in: PubMed
    Score: 0.009
  32. Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel. Mol Endocrinol. 2015 Jun; 29(6):896-908.
    View in: PubMed
    Score: 0.009
  33. Kinin, a mediator of diabetes-induced glomerular hyperfiltration. Diabetes. 1995 Feb; 44(2):156-60.
    View in: PubMed
    Score: 0.009
  34. Insulin-like growth factor I produces renal hyperfiltration by a kinin-mediated mechanism. Am J Physiol. 1994 Jan; 266(1 Pt 2):F102-7.
    View in: PubMed
    Score: 0.009
  35. 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway. PLoS One. 2013; 8(8):e70029.
    View in: PubMed
    Score: 0.008
  36. Altered renal kallikrein and renin gene expression in nephrotic rats and modulation by converting enzyme inhibition. J Clin Invest. 1993 Aug; 92(2):1073-9.
    View in: PubMed
    Score: 0.008
  37. Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy. J Biol Regul Homeost Agents. 2013 Jul-Sep; 27(3):693-703.
    View in: PubMed
    Score: 0.008
  38. Ceacam1 deletion causes vascular alterations in large vessels. Am J Physiol Endocrinol Metab. 2013 Aug 15; 305(4):E519-29.
    View in: PubMed
    Score: 0.008
  39. Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat. J Clin Invest. 1992 May; 89(5):1460-8.
    View in: PubMed
    Score: 0.008
  40. Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney. Kidney Int. 1992 Apr; 41(4):789-95.
    View in: PubMed
    Score: 0.008
  41. Regulation of renal kallikrein synthesis and activation by glucocorticoids. Kidney Int. 1990 Aug; 38(2):212-8.
    View in: PubMed
    Score: 0.007
  42. Renal kallikrein responses to dietary protein: a possible mediator of hyperfiltration. Kidney Int. 1989 Dec; 36(6):1003-10.
    View in: PubMed
    Score: 0.006
  43. The effects of diabetes and insulin on colonic tissue kallikrein. Adv Exp Med Biol. 1989; 247B:669-73.
    View in: PubMed
    Score: 0.006
  44. Abnormal regulation of renal kallikrein in experimental diabetes. Effects of insulin on prokallikrein synthesis and activation. J Clin Invest. 1987 Dec; 80(6):1651-9.
    View in: PubMed
    Score: 0.006
  45. Insulin-like growth factors mediate heterotrimeric G protein-dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors. J Biol Chem. 2006 Oct 20; 281(42):31399-407.
    View in: PubMed
    Score: 0.005
  46. Pioglitazone inhibits connective tissue growth factor expression in advanced atherosclerotic plaques in low-density lipoprotein receptor-deficient mice. Atherosclerosis. 2007 May; 192(1):85-91.
    View in: PubMed
    Score: 0.005
  47. Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin. Blood. 2006 Jul 01; 108(1):192-9.
    View in: PubMed
    Score: 0.005
  48. Studies of the effects of insulin, bradykinin, and captopril on blood glucose levels of alloxan-diabetic rats. Adv Exp Med Biol. 1986; 198 Pt B:373-8.
    View in: PubMed
    Score: 0.005
  49. A comparative study of prokallikreins and kallikreins from rat pancreatic tissue and juice. Adv Exp Med Biol. 1986; 198 Pt A:323-7.
    View in: PubMed
    Score: 0.005
  50. Utilization of a radioimmunoassay to detect the generation of Arg-Pro-Pro-Gly-Phe, a stable endproduct of bradykinin metabolism (from cultured rat aortic smooth muscle cells exposed to bradykinin). Int Immunopharmacol. 2002 Dec; 2(13-14):1995-2003.
    View in: PubMed
    Score: 0.004
  51. Angiotensin peptides modulate bradykinin levels in the interstitium of the dog heart in vivo. J Pharmacol Exp Ther. 2002 Jan; 300(1):324-9.
    View in: PubMed
    Score: 0.004
  52. Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins. Hypertension. 2001 Oct; 38(4):858-63.
    View in: PubMed
    Score: 0.004
  53. Bradykinin B2 receptors activate Na+/H+ exchange in mIMCD-3 cells via Janus kinase 2 and Ca2+/calmodulin. J Biol Chem. 2001 May 18; 276(20):17339-46.
    View in: PubMed
    Score: 0.003
  54. A metabolic fragment of bradykinin, Arg-Pro-Pro-Gly-Phe, protects against the deleterious effects of lipopolysaccharide in rats. J Pharmacol Exp Ther. 2001 Jan; 296(1):71-6.
    View in: PubMed
    Score: 0.003
  55. Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages. Arterioscler Thromb Vasc Biol. 1999 Jul; 19(7):1600-7.
    View in: PubMed
    Score: 0.003
  56. Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells. Hypertension. 1998 Apr; 31(4):978-85.
    View in: PubMed
    Score: 0.003
  57. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide. Hypertension. 1997 Mar; 29(3):757-62.
    View in: PubMed
    Score: 0.003
  58. Renin-angiotensin system modulates renal bradykinin production. Am J Physiol. 1996 Oct; 271(4 Pt 2):R1090-5.
    View in: PubMed
    Score: 0.003
  59. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats. Hypertension. 1996 Feb; 27(2):235-44.
    View in: PubMed
    Score: 0.002
  60. Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake. Hypertension. 1994 Jun; 23(6 Pt 2):1068-70.
    View in: PubMed
    Score: 0.002
  61. Stimulation of renal interstitial bradykinin by sodium depletion. Am J Hypertens. 1993 Oct; 6(10):863-6.
    View in: PubMed
    Score: 0.002
  62. Thromboxane A2/prostaglandin H2 receptors in streptozotocin-induced diabetes: effects of insulin therapy in the rat. Prostaglandins. 1993 May; 45(5):427-38.
    View in: PubMed
    Score: 0.002
  63. Renal hyperfiltration states: relationship to kallikrein and kinins. Agents Actions Suppl. 1992; 38 ( Pt 3):142-8.
    View in: PubMed
    Score: 0.002
  64. Renal kallikrein and hemodynamic abnormalities of diabetic kidney. Diabetes. 1990 Mar; 39(3):299-304.
    View in: PubMed
    Score: 0.002
  65. Measurement of glomerular filtration rate and renal plasma flow in the diabetic rat by the single-injection isotopic technique: effects of altered distribution volumes of 51Cr-EDTA and 125I-hippuran. Diabetes Res. 1988 Oct; 9(2):67-72.
    View in: PubMed
    Score: 0.001
  66. A time-course study of submandibular kallikrein, blood glucose and insulin of alloxan-diabetic and streptozotocin-diabetic rats. Agents Actions. 1984 Dec; 15(5-6):478-81.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.